Olubunmi Olutoyin Afonja
Hematologist-Oncologist | Hematology & Oncology
77 West Haledon Avenue Haledon New Jersey, 7508About
Olubunmi Olutoyin Afonja, MD, works at New York University Medical Center in New York City. Also known as NYU Langone, Dr. Afonja specializes in the treatment of breast cancer, as well as pediatric hematology and oncology. On the adjunct faculty of NYU, Dr. Afonja also treats bone tumors and bone marrow syndrome failures.
Education and Training
University of Ibadan
Board Certification
American Board of Pediatrics- Pediatric Hematology and Oncology
Provider Details
Areas of expertise and specialization
Awards
- Irma T. Hirschal Award and Grant for Jr. Faculty Investigators
- Robert Wood Johnson Foundation Research Award
Fellowships
- NYU Hospital (Pediatric Hematology and Oncology)
Professional Society Memberships
- American Society of Clinical Oncology, American Society of Hematology
Articles and Publications
- 5 Publications as Primary Contributor
What do you attribute your success to?
- Passion, Common Sense, Interest In Learning
Hobbies / Sports
- Reading, Travel
Favorite professional publications
- Blood, Journal of Clinical Oncology, New England Journal of Medicine
Olubunmi Olutoyin Afonja's Practice location
Olubunmi Olutoyin Afonja's reviews
Write ReviewRecommended Articles
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- Living as a Hodgkin Lymphoma Survivor: Creating a New Normal
No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
Nearby Providers
- Pilar Nava-Parada20 W 72nd St New York NY 10023
- Loreta Garretson-Vaivilavicius Other96 Parkway Rochelle Park NJ 07662
- Brian H. Kim350 Engle Street Englewood New Jersey 7631
- Stefan Gluck86 Morris Ave Summit NJ 07901
- Dr. Francis A. Forte M.D.25 Rockwood Pl Englewood NJ 07631
- Dr. Maxwell Janosky M.D.350 Engle St Englewood NJ 07631